These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 34012502)

  • 1. Features, Predictors, and Treatment of Breast Cancer-related Lymphedema.
    Zhang X; Oliveri JM; Paskett ED
    Curr Breast Cancer Rep; 2020 Dec; 12(4):244-254. PubMed ID: 34012502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies.
    Shah C; Vicini FA
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):907-14. PubMed ID: 21945108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Methods, Risk Factors, Prevention, and Management of Breast Cancer-Related Lymphedema: Past, Present, and Future Directions.
    Sayegh HE; Asdourian MS; Swaroop MN; Brunelle CL; Skolny MN; Salama L; Taghian AG
    Curr Breast Cancer Rep; 2017 Jun; 9(2):111-121. PubMed ID: 28894513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions.
    Kilgore LJ; Korentager SS; Hangge AN; Amin AL; Balanoff CR; Larson KE; Mitchell MP; Chen JG; Burgen E; Khan QJ; O'Dea AP; Nye L; Sharma P; Wagner JL
    Ann Surg Oncol; 2018 Oct; 25(10):2948-2952. PubMed ID: 29987599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast Cancer - a long-term observation.
    Rupp J; Hadamitzky C; Henkenberens C; Christiansen H; Steinmann D; Bruns F
    Radiat Oncol; 2019 Mar; 14(1):39. PubMed ID: 30845971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
    Lim SM; Han Y; Kim SI; Park HS
    BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
    Nguyen TT; Hoskin TL; Habermann EB; Cheville AL; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):2972-2980. PubMed ID: 28766228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of providing information about lymphedema on the cognitive and symptom outcomes of breast cancer survivors.
    Fu MR; Chen CM; Haber J; Guth AA; Axelrod D
    Ann Surg Oncol; 2010 Jul; 17(7):1847-53. PubMed ID: 20140528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Disturbance of Lymphatic Transport as a Risk Factor for the Development of Breast-Cancer-Related Lymphedema.
    Thomis S; Devoogdt N; Bechter-Hugl B; Fourneau I
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphedema in survivors of breast cancer.
    He L; Qu H; Wu Q; Song Y
    Oncol Lett; 2020 Mar; 19(3):2085-2096. PubMed ID: 32194706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.
    Gillespie TC; Sayegh HE; Brunelle CL; Daniell KM; Taghian AG
    Gland Surg; 2018 Aug; 7(4):379-403. PubMed ID: 30175055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
    Kaufman DI; Shah C; Vicini FA; Rizzi M
    Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlates of Lymphedema in Women with Breast Cancer: a Case Control Study in Shiraz, Southern Iran.
    Honarvar B; Sayar N; Tahmasebi S; Zakeri Z; Talei A; Rostami S; Khademi S; Sabzi Sarvestani A; Sekhavati E
    Asian Pac J Cancer Prev; 2016; 17(S3):81-6. PubMed ID: 27165213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of Treatment for Breast Cancer-Related Lymphedema: Paradigms for Clinical Practice.
    Smile TD; Tendulkar R; Schwarz G; Arthur D; Grobmyer S; Valente S; Vicini F; Shah C
    Am J Clin Oncol; 2018 Feb; 41(2):178-190. PubMed ID: 28009597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of commonly prescribed medications and the risk of developing breast cancer related lymphedema.
    Meijer EF; Bouta EM; Mendonca C; Skolny MN; Salama LW; Taghian AG; Padera TP
    Clin Res Trials; 2020 Feb; 6(1):. PubMed ID: 32864167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for breast cancer-related lymphedema in patients undergoing 3 years of prospective surveillance with intervention.
    Koelmeyer LA; Gaitatzis K; Dietrich MS; Shah CS; Boyages J; McLaughlin SA; Taback B; Stolldorf DP; Elder E; Hughes TM; French JR; Ngui N; Hsu JM; Moore A; Ridner SH
    Cancer; 2022 Sep; 128(18):3408-3415. PubMed ID: 35797441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of axillary web syndrome and its association with lymphedema in women following breast cancer treatment: a retrospective study.
    Ryans K; Davies CC; Gaw G; Lambe C; Henninge M; VanHoose L
    Support Care Cancer; 2020 Dec; 28(12):5881-5888. PubMed ID: 32270312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated Treatment of Breast Cancer-related Lymphedema: A Descriptive Review of the State of the Art.
    Marchica P; D'Arpa S; Magno S; Rossi C; Forcina L; Capizzi V; Oieni S; Amato C; Piazza D; Gebbia V
    Anticancer Res; 2021 Jul; 41(7):3233-3246. PubMed ID: 34230117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Herremans KM; Cribbin MP; Riner AN; Neal DW; Hollen TL; Clevenger P; Munoz D; Blewett S; Giap F; Okunieff PG; Mendenhall NP; Bradley JA; Mendenhall WM; Mailhot-Vega RB; Brooks E; Daily KC; Heldermon CD; Marshall JK; Hanna MW; Leyngold MM; Virk SS; Shaw CM; Spiguel LR
    Ann Surg Oncol; 2021 Oct; 28(10):5775-5787. PubMed ID: 34365563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.